A transgene consisting of hs1753 (chr7:158,888,320-158,891,362) enhancer element located in intron 4 of human VIPR2 gene subcloned into Hsp68 promoter fused with ERT2CreERT2-pA to drive expression of cre in response to tamoxifen in developing heart. A total of nine transgenic founders lines 1, 17, 20, 22, 23, 29, 30, 32, 33 were obtained. All transgenic lines showed heart-specific cre activity when bred to a cre reporter mouse. Transgenic line 001 exhibited the strongest expression of the reporter gene and was used for further studies.
Find mice (IMSR):
Mouse Strains:
0 strains available
Cell Lines:
0 lines available
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.
Analysis Tools
